STOCK TITAN

Lam Research CEO sells 30K shares at $319

Lam Research’s CEO exercised stock options for 30,000 shares and sold an equal number under a pre-arranged Rule 10b5-1 trading plan.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

LAM RESEARCH CORP (LRCX) reported that President and CEO Timothy Archer exercised employee stock options for 30,000 shares of common stock on September 9, 2026 at an exercise price of $30.033 per share and sold 30,000 shares of common stock at $319.26 per share the same day. The option exercise reduced his option position to 31,400 options, and the sale and related transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2026. Archer also reports indirect holdings of common stock through his 401(k) plan and his spouse’s 401(k) plan.

Positive

  • None.

Negative

  • None.
Insider ARCHER TIMOTHY
Role President and CEO
Sold 30,000 shs ($9.58M)
Approx. gross sale proceeds $9.58M
Approx. exercise cost $901K
Approx. pre-tax spread $8.68M
Type Security Shares Price Value
Exercise Employee Stock Option (Right to Buy) F3 30,000 $0.00 $0.00
Exercise Common Stock F1, F2 30,000 $30.033 $901K
Sale Common Stock F1, F2 30,000 $319.26 $9.58M
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Employee Stock Option (Right to Buy) — 31,400 contracts (Direct); Common Stock — 1,075,966 shares (Direct); Common Stock — 48,025.72 shares (Indirect, By 401(k)); Common Stock — 5,670.002 shares (Indirect, By Spouse 401(k))
Footnotes (3)
  1. F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2026.
  2. F2. The amount reported includes shares subject to unvested restricted stock units.
  3. F3. The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023.
Options exercised 30,000 shares Employee stock option exercise on September 9, 2026
Option exercise price $30.033 per share Exercise price of employee stock option for 30,000 shares
Shares sold 30,000 shares Common stock sale on September 9, 2026
Sale price $319.26 per share Price for sale of 30,000 Lam Research common shares
Options remaining 31,400 options Employee stock options remaining after the reported exercise
Indirect 401(k) holdings 48,025.72 shares Common stock held indirectly by Timothy Archer’s 401(k) plan
Spouse 401(k) holdings 5,670.002 shares Common stock held indirectly by spouse’s 401(k) plan
Option expiration date March 2, 2027 Expiration date of the employee stock options exercised in part
Rule 10b5-1 trading plan regulatory
"transaction was effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Employee Stock Option (Right to Buy) financial
"security title is Employee Stock Option (Right to Buy)"
restricted stock units financial
"amount reported includes shares subject to unvested restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
indirect ownership financial
"shares held indirectly by 401(k) and spouse 401(k) plans"

FAQ

What did LRCX CEO Timothy Archer report on this Form 4?

He exercised options for 30,000 shares of Lam Research common stock at an exercise price of $30.033 per share and sold 30,000 shares at $319.26 per share on September 9, 2026, in transactions tied to a Rule 10b5-1 trading plan.

Were Timothy Archer’s LRCX trades made under a Rule 10b5-1 plan?

Yes. The filing states the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by Timothy Archer on February 24, 2026, and the document-level Rule 10b5-1 checkbox is also affirmed.

What options did the LRCX CEO exercise in this Form 4?

He exercised an employee stock option covering 30,000 shares of Lam Research common stock at an exercise price of $30.033 per share. After this exercise, 31,400 options from that grant remain outstanding, with an expiration date of March 2, 2027.

At what price did Timothy Archer sell LRCX shares?

He sold 30,000 shares of Lam Research common stock at a reported price of $319.26 per share on September 9, 2026, in a sale categorized as a sale in open market or private transaction.

What indirect LRCX holdings does the CEO report?

Timothy Archer reports indirect ownership of 48,025.72 shares of Lam Research common stock through his 401(k) plan and 5,670.002 shares through his spouse’s 401(k) plan, both listed as indirect holdings.

Do the CEO’s reported holdings include unvested restricted stock units in LRCX?

Yes. A footnote states that the amount reported includes shares subject to unvested restricted stock units, indicating that some of the reported common stock holdings relate to RSUs that have not yet vested.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ARCHER TIMOTHY

(Last)(First)(Middle)
4650 CUSHING PARKWAY

(Street)
FREMONT CALIFORNIA 94538

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
LAM RESEARCH CORP [ LRCX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/09/2026M30,000(1)A$30.0331,105,966(2)D
Common Stock09/09/2026S30,000(1)D$319.261,075,966(2)D
Common Stock48,025.72IBy 401(k)
Common Stock5,670.002IBy Spouse 401(k)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy)$30.03309/09/2026M30,000 (3)03/02/2027Common Stock30,000$031,400D
Explanation of Responses:
1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2026.
2. The amount reported includes shares subject to unvested restricted stock units.
3. The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023.
Remarks:
Marta Woods by Power of Attorney09/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading